*  New Descriptors by Tree Subcategory - 2015

C25 (Chemically-Induced Disorders). Cardiotoxicity. Metabolic Side Effects of Drugs and Substances. Nicolau Syndrome ... Premenstrual Dysphoric Disorder. Protein Aggregation, Pathological. Squamous Intraepithelial Lesions of the Cervix. Vascular ...
https://nlm.nih.gov/mesh/newbysub.html

*  Combined Pharmacotherapy for Cannabis Dependency - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Dronabinol. Clonidine. Lofexidine. Hallucinogens. ... Cannabis use disorders remain the most common illicit drug use disorder and options for treatment remain limited. Compared to ... and cue-induced related stress such that the combination will act in a complementary manner to induce prolonged abstinence from ... Agonist pharmacotherapy strategies have been effective for other substance use disorders (e.g., opioid and nicotine use ...
https://clinicaltrials.gov/ct2/show/NCT01020019?term=cannabis&lup_s=03/17/2014&lup_d=30

*  Substance Use Risk Education (SURE) Project - Full Text View - ClinicalTrials.gov

Alcohol-Related Disorders. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Drinking Behavior. ...
https://clinicaltrials.gov/ct2/show/NCT00289965

*  Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer - Full Text...

Chemically-Induced Disorders. Paclitaxel. Albumin-Bound Paclitaxel. Cisplatin. Amifostine. Antineoplastic Agents, Phytogenic. ... A Limited Access Trial Using Amifostine for Protection Against Cisplatin and 3-Hour Paclitaxel-Induced Neurotoxicity. ... Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a ...
https://clinicaltrials.gov/ct2/show/NCT00003624?term=Neurotoxicity&rank=20

*  WHC+ (Women's Health CoOp PLUS) - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Sexually Transmitted Diseases. Chemically-Induced Disorders. Mental Disorders. Infection. Virus ...
https://clinicaltrials.gov/ct2/show/NCT01497405?term=HIV transmission AND Treatment of sexually transmitted disease OR prevention of STD OR prevention of STI OR treatment of STD OR treatment of STI OR prevention of sexually transmitted disease&recr=Open&rank=18

*  Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia - Full Text View - ClinicalTrials.gov

Opioid-Related Disorders. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Buprenorphine. ... current dependence on alcohol, benzodiazepines or sedatives current suicide or homicide risk current psychotic disorder or ...
https://clinicaltrials.gov/show/NCT00539123?order=716

*  RCSB PDB - Ligand Summary Page

Chemically-Induced Disorders. *Cytochrome P-450 CYP1A2 Inhibitors. *Cytochrome P-450 CYP2B6 Inducers ...
rcsb.org/pdb/ligand/ligandsummary.do?handler=biologyChemistry&hetId=EFZ

*  Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence - Full Text View - ClinicalTrials.gov

Tobacco Use Disorder. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. Ganglionic ...
https://clinicaltrials.gov/ct2/show/NCT01627392

*  Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study - Full Text View -...

Chemically-Induced Disorders. Raltegravir Potassium. Protease Inhibitors. HIV Protease Inhibitors. Reverse Transcriptase ... Patients with any medical disorder or history of any illness which, in the opinion of the investigator, that the use of study ...
https://clinicaltrials.gov/show/NCT01679964

*  Intensive Enteral Nutrition and Acute Alcoholic Hepatitis - Full Text View - ClinicalTrials.gov

Alcohol-Induced Disorders. Alcohol-Related Disorders. Substance-Related Disorders. Chemically-Induced Disorders. ...
https://clinicaltrials.gov/ct2/show/NCT01801332?cond="Hepatitis, Alcoholic"&rank=20

*  Smoking Treatment in HIV Clinical Care Settings - Full Text View - ClinicalTrials.gov

Tobacco Use Disorder. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. Ganglionic ...
https://clinicaltrials.gov/show/NCT00297453?order=658

*  Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug...

Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Buprenorphine. Buprenorphine, Naloxone Drug ... Opioid-Related Disorders. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. Sexually ...
https://clinicaltrials.gov/ct2/show/NCT00270257

*  Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Sexually Transmitted Diseases. Chemically-Induced Disorders. Mental Disorders. Infection. Virus ... Sexually Transmitted Diseases Unsafe Sex Substance-Related Disorders Behavioral: PACT Behavioral: TAU ...
https://clinicaltrials.gov/show/NCT01690494?order=416

*  Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients - Full Text View - ClinicalTrials.gov

Chemically-Induced Disorders. Interferons. Ribavirin. Interferon-alpha. Antineoplastic Agents. Antiviral Agents. To Top ... Depressive Disorder. Hepatitis. Hepatitis C. HIV Infections. Substance-Related Disorders. Depressive Disorder, Major. ... Severe comorbid psychiatric disease including bipolar disorder, severe personality disorder, or psychotic disorder ... Mood Disorders. Peginterferon alfa-2a. Hepatitis C. Interferon Alfa-2a. Interferon Alfa-2b. Depressive Disorder, Major. ...
https://clinicaltrials.gov/show/NCT00655226?order=197

*  Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers - Full Text View - ClinicalTrials.gov

Tobacco Use Disorder. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. ClinicalTrials.gov processed ... Tobacco Use Disorder Other: Camel Snus Other: Marlboro Snus Other: Stonewall Other: Ariva Other: General Snus ...
https://clinicaltrials.gov/ct2/show/NCT00711100

*  Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 - Full Text View - ClinicalTrials.gov

Opioid-Related Disorders. Heroin Dependence. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. ... Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical ... Heroin Dependence Opioid-Related Disorders Drug: Test Drug Drug: Placebo Drug Phase 2 ... Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) ...
https://clinicaltrials.gov/ct2/show/NCT00000331

*  Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users - Full Text View - ClinicalTrials.gov

Chemically-Induced Disorders. Mental Disorders. Infection. Genital Diseases, Male. Genital Diseases, Female. Methamphetamine. ... Substance-Related Disorders. Sexually Transmitted Diseases. Lentivirus Infections. Retroviridae Infections. RNA Virus ...
https://clinicaltrials.gov/show/NCT00432926?order=118

*  Buprenorphine and Integrated HIV Care Evaluation - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Analgesics, Opioid. Buprenorphine. Narcotics. ... Drug Use Disorder. Substance Abuse. Substance Use Disorder. Buprenorphine. Opiate Addiction. Substance-related disorders. HIV. ... Opioid-Related Disorders HIV Infections AIDS Drug: Buprenorphine Behavioral: Integrated HIV care and office-based opioid ... Opioid-Related Disorders. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. Sexually ...
https://clinicaltrials.gov/show/NCT00124358?order=260

*  Smoking Cessation Intervention: Effectiveness in Primary Care - Full Text View - ClinicalTrials.gov

Tobacco Use Disorder. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. Bupropion. ... Uncontrolled hypertension (systolic ,180mm Hg or diastolic ,110mm Hg) - History of bipolar disorder or psychosis - Myocardial ...
https://clinicaltrials.gov/ct2/show/study/NCT00296647?view=results

*  Effectiveness of Cannabis in the Treatment of Tinnitus Patients - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. To Top. *For Patients and Families ... Hearing Disorders. Ear Diseases. Otorhinolaryngologic Diseases. Sensation Disorders. Neurologic Manifestations. Nervous System ...
https://clinicaltrials.gov/ct2/show/NCT01969474?recr=Open&cond="Tinnitus"&rank=9

*  Transitions: Linkages From Jail To Community - Full Text View - ClinicalTrials.gov

Chemically-Induced Disorders. Mental Disorders. To Top. *For Patients and Families. *For Researchers ... Substance-Related Disorders. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. Sexually ... Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected ...
https://clinicaltrials.gov/show/NCT00841711?order=189

*  Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users - Full Text View - ClinicalTrials...

Chemically-Induced Disorders. Mental Disorders. Antidepressive Agents. Psychotropic Drugs. ClinicalTrials.gov processed this ... Diagnosed with bipolar disorder, schizophrenia, schizoaffective disorder, schizophreniform disorder, or paranoid disorder ... Substance-Related Disorders. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. Sexually ... DSM-IV diagnosis of major depression, dysthymia, substance-induced major depression, or major depression plus dysthymia ...
https://clinicaltrials.gov/show/NCT00228007?order=643

*  Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation - Full Text View - ClinicalTrials.gov

Tobacco Use Disorder. Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Nicotine. Varenicline. ... Current psychiatric disease (with the exception of anxiety disorders, Obsessive-compulsive disorder (OCD) and Attention deficit ... Active skin disorder (e.g., psoriasis) within the last five years, except minor skin conditions (including but not limited to ... Cardiac rhythm disorder (irregular heart rhythm);. *Chest pains (unless history, exam, and ECG clearly indicate a non-cardiac ...
https://clinicaltrials.gov/show/NCT01406223

*  HIV Risk Reduction and Drug Abuse Treatment in Malaysia - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Opioid-Related Disorders. Chemically-Induced Disorders. Mental Disorders. Buprenorphine. ...
https://clinicaltrials.gov/show/NCT00383045?order=664

*  Jail-Based Impact of Crime Intervention - Full Text View - ClinicalTrials.gov

Substance-Related Disorders. Chemically-Induced Disorders. Mental Disorders. To Top. *For Patients and Families ...
https://clinicaltrials.gov/show/NCT01378936?order=56

(1/2) Identification of workers exposed concomitantly to heat stress and chemicals.

In the context of climate change, concomitant exposure to heat stress and chemicals takes on great importance. However, little information is available in this regard. The purpose of this research, therefore, was to develop an approach aimed at identifying worker groups that would be potentially most at risk. The approach comprises 5 consecutive steps: - Establishment of a list of occupations for all industry sectors - Determination of heat stress parameters - Identification of occupations at risk of heat stress - Determination of exposure to chemicals - Identification of occupations potentially most at risk. Overall, 1,010 occupations were selected due to their representativeness of employment sectors in Quebec. Using a rating matrix, the risk stemming from exposure to heat stress was judged "critical" or "significant" for 257 occupations. Among these, 136 occupations were identified as showing a high potential of simultaneous exposure to heat stress and chemicals. Lastly, a consultation with thirteen experts made it possible to establish a list of 22 priority occupations, that is, 20 occupations in the metal manufacturing sector, as well as roofers and firefighters. These occupations would merit special attention for an investigation and evaluation of the potential effects on workers' health.  (+info)

(2/2) Student preferences regarding teaching methods in a drug-induced diseases and clinical toxicology course.

 (+info)


Mental Disorders


  • Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation. (clinicaltrials.gov)

nicotine


  • Agonist pharmacotherapy strategies have been effective for other substance use disorders (e.g., opioid and nicotine use disorders) and the endocannabinoid system represents a promising target for agonist pharmacotherapy with dronabinol. (clinicaltrials.gov)

psychiatric disorders


  • Meets DSM-IV-TR criteria for schizophrenia, schizoaffective illness, psychotic disorder other than transient psychosis due to drug abuse, major depression, bipolar illness or psychiatric disorders (other than substance abuse) which require psychiatric intervention. (clinicaltrials.gov)

cannabis


  • Cannabis use disorders remain the most common illicit drug use disorder and options for treatment remain limited. (clinicaltrials.gov)
  • Lofexidine, a noradrenergic system suppressant, is effective in treating opioid withdrawal and shows promise as a cannabis use disorder pharmacotherapy. (clinicaltrials.gov)

treatment


  • The primary hypothesis is that dronabinol will act as an agonist treatment while lofexidine will suppress craving- and cue-induced related stress such that the combination will act in a complementary manner to induce prolonged abstinence from marijuana. (clinicaltrials.gov)